242 related articles for article (PubMed ID: 30467901)
1. Urinary aquaporin 1 and perilipin 2: Can these novel markers accurately characterize small renal masses and help guide patient management?
Song JB; Morrissey JJ; Mobley JM; Figenshau KG; Vetter JM; Bhayani SB; Kharasch ED; Figenshau RS
Int J Urol; 2019 Feb; 26(2):260-265. PubMed ID: 30467901
[TBL] [Abstract][Full Text] [Related]
2. Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer.
Morrissey JJ; Mobley J; Figenshau RS; Vetter J; Bhayani S; Kharasch ED
Mayo Clin Proc; 2015 Jan; 90(1):35-42. PubMed ID: 25572193
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma: A Prospective Cohort Study.
Morrissey JJ; Mellnick VM; Luo J; Siegel MJ; Figenshau RS; Bhayani S; Kharasch ED
JAMA Oncol; 2015 May; 1(2):204-12. PubMed ID: 26181025
[TBL] [Abstract][Full Text] [Related]
4. Urinary concentrations of aquaporin-1 and perilipin-2 in patients with renal cell carcinoma correlate with tumor size and stage but not grade.
Morrissey JJ; Mobley J; Song J; Vetter J; Luo J; Bhayani S; Figenshau RS; Kharasch ED
Urology; 2014 Jan; 83(1):256.e9-14. PubMed ID: 24239027
[TBL] [Abstract][Full Text] [Related]
5. Screening for kidney cancer: is there a role for aquaporin-1 and adipophilin?
Grebe SK; Erickson LA
Mayo Clin Proc; 2010 May; 85(5):410-2. PubMed ID: 20435833
[No Abstract] [Full Text] [Related]
6. Diagnostic performance of prospectively assigned clear cell Likelihood scores (ccLS) in small renal masses at multiparametric magnetic resonance imaging.
Johnson BA; Kim S; Steinberg RL; de Leon AD; Pedrosa I; Cadeddu JA
Urol Oncol; 2019 Dec; 37(12):941-946. PubMed ID: 31540830
[TBL] [Abstract][Full Text] [Related]
7. Urinary biomarkers for the early diagnosis of kidney cancer.
Morrissey JJ; London AN; Luo J; Kharasch ED
Mayo Clin Proc; 2010 May; 85(5):413-21. PubMed ID: 20375178
[TBL] [Abstract][Full Text] [Related]
8. Urinary KIM-1 and AQP-1 in patients with clear renal cell carcinoma: Potential noninvasive biomarkers.
Mijugković M; Stanojević I; Milović N; Cerović S; Petrović D; Jovanović D; Aleksić P; Kovacević B; Andjelić T; Terzic B; Djukić M; Vojvodić D
Vojnosanit Pregl; 2016 Mar; 73(3):266-72. PubMed ID: 27295912
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Identify Clear Cell Renal Cell Carcinoma in cT1a Renal Masses.
Canvasser NE; Kay FU; Xi Y; Pinho DF; Costa D; de Leon AD; Khatri G; Leyendecker JR; Yokoo T; Lay A; Kavoussi N; Koseoglu E; Cadeddu JA; Pedrosa I
J Urol; 2017 Oct; 198(4):780-786. PubMed ID: 28457802
[TBL] [Abstract][Full Text] [Related]
10. The specificity of urinary aquaporin 1 and perilipin 2 to screen for renal cell carcinoma.
Morrissey JJ; Kharasch ED
J Urol; 2013 May; 189(5):1913-20. PubMed ID: 23154208
[TBL] [Abstract][Full Text] [Related]
11. An In-vivo Prospective Study of the Diagnostic Yield and Accuracy of Optical Biopsy Compared with Conventional Renal Mass Biopsy for the Diagnosis of Renal Cell Carcinoma: The Interim Analysis.
Buijs M; Wagstaff PGK; de Bruin DM; Zondervan PJ; Savci-Heijink CD; van Delden OM; van Leeuwen TG; van Moorselaar RJA; de la Rosette JJMCH; Laguna Pes MP
Eur Urol Focus; 2018 Dec; 4(6):978-985. PubMed ID: 29079496
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous core biopsy for renal masses: indications, accuracy and results.
Lebret T; Poulain JE; Molinie V; Herve JM; Denoux Y; Guth A; Scherrer A; Botto H
J Urol; 2007 Oct; 178(4 Pt 1):1184-8; discussion 1188. PubMed ID: 17698122
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous biopsy of renal cell carcinoma underestimates nuclear grade.
Blumenfeld AJ; Guru K; Fuchs GJ; Kim HL
Urology; 2010 Sep; 76(3):610-3. PubMed ID: 20163843
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a multiparametric renal CT algorithm for diagnosis of clear-cell renal cell carcinoma among small (≤ 4 cm) solid renal masses.
Eldihimi F; Walsh C; Hibbert RM; Nasibi KA; Pickovsky JS; Schieda N
Eur Radiol; 2024 Jun; 34(6):3992-4000. PubMed ID: 37968475
[TBL] [Abstract][Full Text] [Related]
15. Current management of small renal masses.
Martínez Rodríguez C; Tardáguila de la Fuente G; Villanueva Campos AM
Radiologia (Engl Ed); 2020; 62(3):167-179. PubMed ID: 31882171
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma.
Mytsyk Y; Dosenko V; Borys Y; Kucher A; Gazdikova K; Busselberg D; Caprnda M; Kruzliak P; Farooqi AA; Lubov M
Int Urol Nephrol; 2018 May; 50(5):851-859. PubMed ID: 29549624
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging of small renal masses in real practice: sensitivity and specificity according to subjective radiologic interpretation.
Kim JH; Sun HY; Hwang J; Hong SS; Cho YJ; Doo SW; Yang WJ; Song YS
World J Surg Oncol; 2016 Oct; 14(1):260. PubMed ID: 27729042
[TBL] [Abstract][Full Text] [Related]
18. Value of urinary NMP-22 in patients with renal cell carcinoma.
Ozer G; Altinel M; Kocak B; Yazicioglu A; Gonenc F
Urology; 2002 Oct; 60(4):593-7. PubMed ID: 12385914
[TBL] [Abstract][Full Text] [Related]
19. Treating the two extremes in renal cell carcinoma: management of small renal masses and cytoreductive nephrectomy in metastatic disease.
Kim DY; Wood CG; Karam JA
Am Soc Clin Oncol Educ Book; 2014; ():e214-21. PubMed ID: 24857105
[TBL] [Abstract][Full Text] [Related]
20. Urinary Biomarkers for the Detection and Management of Localized Renal Cell Carcinoma.
Rini BI; Campbell SC
JAMA Oncol; 2015 May; 1(2):212-3. PubMed ID: 26181026
[No Abstract] [Full Text] [Related]
[Next] [New Search]